NCODA
MENUMENU
  • About
    • Meet NCODA
    • Awards
    • Staff
    • Executive Council
    • Advisory Board
    • Legislative & Policy Advisory Committee
    • Corporate Sponsors & Supporters
  • Initiatives
    • Cost Avoidance & Waste Tracker
    • Positive Quality Intervention
    • Oral Chemotherapy Education
    • Treatment Support Kit
    • PQI in Action
    • Financial Assistance
    • Patient Surveys
    • Readiness Tracker
  • Events
    • Fall Summit
    • Spring Forum
    • Oncology Institute
    • Poster Presentations Opportunities
    • Program Sponsors & Exhibitors
  • Membership
    • Become a Member
    • Practice in Focus
  • Community
    • Association Management Advanced Pharmacy Practice Experience
    • Be The Match
    • Committees
    • Oncology Association Management Fellowship
    • Professional Student Organizations
  • News
  • OPTA
  • Oncolytics Today
  • COVID-19 Resources
  • Login
  • Register
  • Contact

B-Cell Malignancies: Exploring the Influence of BTK Inhibitors and Practical Interventions on Patient Outcomes

Home Docs B-Cell Malignancies: Exploring the Influence of BTK Inhibitors and Practical Interventions on Patient Outcomes

  • All Docs

Presentations’s Docs ▸ B-Cell Malignancies: Exploring the Influence of BTK Inhibitors and Practical Interventions on Patient Outcomes

  • Read

Kirollos S. Hanna, PharmD, BCPS, BCOP

Oncology Pharmacy Manager

M Health Fairview

Assistant Professor

Mayo Clinic College of Medicine

Maple Grove, Minnesota

Attachments

  • B-Cell-Malignancies_Hanna_PTCE-NCODA_Final-for-Handout-002.pdf

Passion for Patients

  • 315-655-4640
  • contact@ncoda.org